Dallas Hack
Chief Executive Officer at VirTech Bio, Inc.
Net worth: 207 $ as of 2024-04-29
Profile
Dallas C.
Hack is currently the Chief Executive Officer & Director at VirTech Bio, Inc. He is also a Director at SteriLumen, Inc. and Hemispherian AS.
Previously, he served as an Independent Director at Applied UV, Inc. from 2020 to 2024.
He was also an Associate Professor at Virginia Commonwealth University and a Member of the Order of Military Medical Merit.
Dr. Hack holds an undergraduate degree from Andrews University, a graduate degree from The Johns Hopkins University, a doctorate degree from Loma Linda University, and a graduate degree from the U.S.
Army War College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
APPLIED UV, INC.
0.01% | 2024-04-15 | 360 ( 0.01% ) | 207 $ | 2024-04-29 |
Dallas Hack active positions
| Companies | Position | Start |
|---|---|---|
SteriLumen, Inc.
 SteriLumen, Inc. Industrial MachineryProducer Manufacturing Part of Applied UV, Inc., SteriLumen, Inc. is a company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn. | Director/Board Member | - |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Director/Board Member | - |
VirTech Bio, Inc.
 VirTech Bio, Inc. BiotechnologyHealth Technology VirTech Bio, Inc. operates as a biotechnology company. It develops innovative therapies for organ and tissue preservation. The company was founded in 2013 and is headquartered in Beverly, MA. | Chief Executive Officer | 2022-03-16 |
Former positions of Dallas Hack
| Companies | Position | End |
|---|---|---|
| APPLIED UV, INC. | Director/Board Member | 2024-05-05 |
| Virginia Commonwealth University | Corporate Officer/Principal | 2014-12-31 |
| Order of Military Medical Merit | Corporate Officer/Principal | - |
Training of Dallas Hack
| Andrews University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| Loma Linda University | Doctorate Degree |
| U.S. Army War College | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APPLIED UV, INC. | Process Industries |
| Private companies | 4 |
|---|---|
SteriLumen, Inc.
SteriLumen, Inc. Industrial MachineryProducer Manufacturing Part of Applied UV, Inc., SteriLumen, Inc. is a company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn. | Producer Manufacturing |
VirTech Bio, Inc.
VirTech Bio, Inc. BiotechnologyHealth Technology VirTech Bio, Inc. operates as a biotechnology company. It develops innovative therapies for organ and tissue preservation. The company was founded in 2013 and is headquartered in Beverly, MA. | Health Technology |
| Order of Military Medical Merit | |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Commercial Services |
- Stock Market
- Insiders
- Dallas Hack
